Kurdish Man Dies in Failed Attempt to Rescue Drowning Woman in Erbil

 A Kurdish flag hangs in the Erbil International Airport, in Iraq, September 27, 2017. (AP/Khalid Mohammed)
A Kurdish flag hangs in the Erbil International Airport, in Iraq, September 27, 2017. (AP/Khalid Mohammed)
TT

Kurdish Man Dies in Failed Attempt to Rescue Drowning Woman in Erbil

 A Kurdish flag hangs in the Erbil International Airport, in Iraq, September 27, 2017. (AP/Khalid Mohammed)
A Kurdish flag hangs in the Erbil International Airport, in Iraq, September 27, 2017. (AP/Khalid Mohammed)

On the third day of Eid al-Fitr, Iraqi woman Zahra Hashim, 36, was resting on a chair near the Choman river in the Balakayati area, in Rwanduz town northeast of Erbil, enjoying the beauty of the village’s nature as she got dragged by the water stream in no time.

Despite her screams and cries, none of her three children or family members who were with her made a move to rescue Zahra.

However, Jabar Osman Said, 19, a young Kurdish man who was on an overlooking hill, jumped and tried to rescue the woman, who clung to his arm with great force, but the water flow was stronger than him, and both the young man and the woman were swept away from the village by one kilometer, to end up drowning together in the river.

Sarkar Othman, 13, Jabar’s younger brother, confirmed that his brother was close to the scene, when he suddenly heard the scream of the drowning woman.

He told Asharq Al-Awsat that she grabbed his brother's arm strongly and dragged him to the depth.

“My brother could not resist the strength of the lady and the power of the current, which dragged them together to the depth away from the village.”

Ali Balaki, the young man's uncle, said that the villagers will rush to rescue anyone drowning in that river. One of his nephews also drowned last year while rescuing a man dragged by the river.

"Our family is always keen to provide help for people, regardless of their identity. This is part of our customs and traditions in this region.”

The Kurdistan Tourism Authority called on tourists from Iraq's central and southern governorates to fully comply with the guidelines of the Tourism and Civil Defense Authority and to exercise extreme caution in the mountainous tourist areas and to avoid the dangerous spots.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”